Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
33
NMPA:33
Drug Approvals
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20237090
- Approval Date
- Aug 11, 2023
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20237091
- Approval Date
- Aug 11, 2023
NMPA
DICLOFENAC SODIUM EYE DROPS
- Product Name
- 双氯芬酸钠滴眼液
- Approval Number
- 国药准字H20074033
- Approval Date
- Dec 8, 2022
NMPA
Pazufloxacin Mesilate Injection
- Product Name
- 加易尼
- Approval Number
- 国药准字H20061054
- Approval Date
- Mar 16, 2021
NMPA
Ciprofloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸环丙沙星滴眼液
- Approval Number
- 国药准字H20055979
- Approval Date
- Aug 11, 2020
NMPA
Promethazine Hydrochloride Injection
- Product Name
- 盐酸异丙嗪注射液
- Approval Number
- 国药准字H32021438
- Approval Date
- Aug 11, 2020
NMPA
Diphenhydramine Hydrochloride Injection
- Product Name
- 盐酸苯海拉明注射液
- Approval Number
- 国药准字H32021435
- Approval Date
- Aug 11, 2020
NMPA
Promethazine Hydrochloride Injection
- Product Name
- 盐酸异丙嗪注射液
- Approval Number
- 国药准字H32021437
- Approval Date
- Aug 11, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found